Promoting Competition
and Investment in the
U.S. Life Sciences Ecosystem
The U.S. life sciences ecosystem depends on mergers and acquisitions (M&A) to bring together the resources, investment and expertise needed to develop and deliver treatments and cures for patients.
FUELING COMPETITION AND INVESTMENT
M&A drives competition and investment across America's life sciences industry.
FACILITATING INNOVATION
Life sciences companies of all sizes engage in M&A to connect innovations with the resources needed to bring them to market.
DRIVING AMERICAN GROWTH, LEADERSHIP
M&A plays a critical role within America’s world-class life sciences industry.
biopharmaceutical companies headquartered in the U.S.
PARTNERS
ABOUT US
PULSE is a national coalition raising awareness about the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. M&A enables life sciences companies of all sizes to bring together resources, investment and expertise needed to develop and deliver new treatments and cures. PULSE members represent researchers, manufacturers and leaders of life sciences companies of all sizes that make up a diverse, vibrant life sciences industry across America.
LATEST NEWS
By the Numbers: Citeline’s R&D Annual Review Underscores Importance of Life Sciences M&A
Findings from Citeline’s latest report, Pharma R&D Annual Review 2026, highlight the continued U.S. leadership in the life sciences ecosystem.
ICYMI: ITIF Report Underscores the Importance of Balanced Antitrust Enforcement
A recent report from the Information Technology and Innovation Foundation (ITIF), “Antitrust Undone: How Competition Enforcers Are Undermining Competition,” highlights the risks of unnecessarily aggressive antitrust enforcement in innovative industries. The report cautions that such policies could, “adversely impact U.S. global competitiveness and innovative dynamism.”
Innovations Advanced by M&A: A New Treatment for Hyperkalemia
AstraZeneca’s acquisition of ZS Pharma helped bring a treatment for hyperkalemia to patients globally.